22 §2698-A. Marketing costs (REPEALED)
§2698-A. Marketing costs (REPEALED) SECTION HISTORY RR 2003, c. 1, §17 (RAL). RR 2003, c. 1, §18 (AFF). PL 2003, c. 688, §C8 (AMD). PL 2005, c. 286, §§1,2 (AMD). PL 2011, c. 461, §3 (RP).
22 §2698-B. Actual price disclosure and certification (REPEALED)
§2698-B. Actual price disclosure and certification (REPEALED) SECTION HISTORY PL 2003, c. 667, §1 (NEW). PL 2003, c. 667, §2 (AFF). PL 2005, c. 402, §§1-4 (AMD). PL 2011, c. 461, §4 (RP).
22 §2699. Prescription drug practices (REPEALED)
§2699. Prescription drug practices (REPEALED) SECTION HISTORY RR 2003, c. 1, §17 (RAL). RR 2003, c. 1, §18 (AFF). PL 2003, c. 430, §1 (NEW). PL 2003, c. 430, §3 (AFF). PL 2003, c. 456, §1 (NEW). PL 2003, c. 673, §§FFF1,2 (AMD). PL 2003, c. 688, §§C9,10 (AMD). PL 2003, c. 688, §C11 (AFF). […]
22 §2700. Unused Pharmaceutical Disposal Program
§2700. Unused Pharmaceutical Disposal Program 1. Establishment; purpose. There is established the Unused Pharmaceutical Disposal Program, referred to in this chapter as “the program.” The purpose of the program is to ensure the safe, effective and proper disposal of unused pharmaceuticals. For purposes of compliance with federal law and regulation, the return of pharmaceuticals under […]
22 §2700-A. Prohibitions
§2700-A. Prohibitions 1. Definitions. As used in this chapter, unless the context otherwise indicates, the following terms have the following meanings. A. [PL 2011, c. 461, §5 (RP).] B. “Manufacturer of prescription drugs” or “manufacturer” means a manufacturer of prescription drugs or biological products or an affiliate of the manufacturer or a labeler that […]
22 §2669. Penalties
§2669. Penalties The department may seek injunctive or other appropriative judicial relief for violations of any provisions of this chapter. [PL 1985, c. 150 (NEW).] SECTION HISTORY PL 1985, c. 150 (NEW).
22 §2697. Profiteering in prescription drugs
§2697. Profiteering in prescription drugs Prescription drugs are a necessity of life. Profiteering in prescription drugs is unlawful and is subject to the provisions of this section. The provisions of this section apply to manufacturers, distributors and labelers of prescription drugs. [PL 1999, c. 786, Pt. A, §3 (NEW).] 1. Definitions. As used in […]
22 §2671. Definitions
§2671. Definitions As used in this chapter, unless the context otherwise indicates, the following terms have the following meanings. [PL 2015, c. 418, §1 (NEW).] 1. Eligible patient. “Eligible patient” means a person who has: A. Received a diagnosis of a terminal illness for which no standard treatment is effective and the diagnosis […]
22 §2698. Investigation by Attorney General
§2698. Investigation by Attorney General The Attorney General, upon the Attorney General’s own initiative or upon petition of the commissioner or of 50 or more residents of the State, shall investigate suspected violations of this subchapter. [PL 1999, c. 786, Pt. A, §3 (NEW).] The Attorney General may require, by summons, the attendance and […]
22 §2672. Availability of investigational drug, biological product or device by manufacturer
§2672. Availability of investigational drug, biological product or device by manufacturer A manufacturer of an investigational drug, biological product or device may make available the investigational drug, biological product or device to an eligible patient. [PL 2015, c. 418, §1 (NEW).] 1. Compensation. A manufacturer may provide an investigational drug, biological product or device […]